TrialThe European respiratory journal2019

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.

Pauline T Lukey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.